Showing results (71-80 of 143) with videos related to

Sort By:
Pageof 15
Oncology|February 17, 2017
Outcome of Patients with Renal Cell Carcinoma and Multiple Glandular Metastases Treated with Targeted AgentsPaolo Grassi, Ludovic Doucet, Palma Giglione, et al.
Annals of Surgical Oncology|June 24, 2016
Sirolimus in Advanced Epithelioid Hemangioendothelioma: A Retrospective Case-Series Analysis from the Italian Rare Cancer Network DatabaseSilvia Stacchiotti, Salvatore Provenzano, Gianpaolo Dagrada, et al.
Cells|June 19, 2024
First-Line Treatments and Management of Metastatic Renal Cell Carcinoma Patients: An Italian Interdisciplinary Uro-Oncologic Group AlgorithmFrancesco Bloise, Fiorella Manfredi, Luca Zatteri, et al.
Clinical Genitourinary Cancer|May 17, 2024
Front-Line Therapeutic Strategy in Metastatic Hormone Sensitive Prostate Cancer: An Updated Therapeutic AlgorithmFederico Paolieri, Enrico Sammarco, Marco Ferrari, et al.
Clinical Genitourinary Cancer|November 27, 2019
Survival Outcomes From a Cumulative Analysis of Worldwide Observational Studies on Sequential Use of New Agents in Metastatic Castration-Resistant Prostate CancerOrazio Caffo, Michel Wissing, Diletta Bianchini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 7, 2020
Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223Orazio Caffo, Viviana Frantellizzi, Marcello Tucci, et al.
Clinical Genitourinary Cancer|January 1, 2020
On-target Toxicities Predictive of Survival in Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: A Multicenter Retrospective StudyElena Bolzacchini, Graziella Pinotti, Lorenza Bertù, et al.
World Journal of Clinical Oncology|December 15, 2021
First-line pazopanib in patients with advanced non-clear cell renal carcinoma: An Italian case seriesSebastiano Buti, Melissa Bersanelli, Francesco Massari, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 18, 2019
[<sup>18</sup>F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancerFrancesco Pasqualetti, Marco Panichi, Martina Sollini, et al.
Clinical Genitourinary Cancer|June 29, 2022
Primary Tumor Shrinkage and the Effect on Metastatic Disease and Outcomes in Patients With Advanced Kidney Cancer With Intermediate or Poor Prognosis Treated With Nivolumab Plus Ipilimumab or CabozantinibRoberto Iacovelli, Chiara Ciccarese, Marco Maruzzo, et al.
Pageof 15